European Commission Spokesperson: The EU fully supports the people of Denmark and Greenland.

U.S. chip stocks were generally down before the market opened, with Arm (ARM.O) falling 3.8%, SanDisk (SNDK.O) falling 6.3%, and Qualcomm (QCOM.O) falling 2.2%. Nvidia (NVDA.O) fell 1.9%, Micron Technology (MU.O) fell 5%, Advanced Micro Devices (AMD.O) fell 2.5% and Intel (INTC.O) fell about 5%.

HSBC: Ended its overweight rating on emerging market stocks. Upgraded Eurozone equities to overweight rating.

Overseas technology news confirmed that OpenAI's GPT-5.6 flagship model (Sol, Terra and Luna sequences) has been approved by the U.S. Department of Commerce and will be fully rolled out to the public this Thursday (July 9); and Musk's SpaceX AI's Grok 4.5 (which integrates Cursor programming data) also announced the completion of private beta testing and will officially launch its public beta tomorrow. In addition to the upcoming official versions of Google Gemini 3.5 Pro and DeepSeek V4, Global AI laboratories are being forced from "quarterly updates" to an arms race of "weekly or even monthly updates." Major manufacturers are eager to bring models to the market, essentially to use terminal computing power output to hedge against Wall Street's strict scrutiny of sky-high CapEx before the second quarter earnings season. Constellation Research and public market data show that the competitive logic of cutting-edge models is undergoing profound differentiation: on the one hand, OpenAI and Grok pursue trillion/trillion-level (1.5T+V9 architecture) extreme reasoning capabilities; On the other hand, DeepSeek V4 has quickly gained share in the open source market and Agent scenarios with its extremely high Token cost-benefit ratio (such as as low as $0.09 per million Tokens). This comparison made the market realize that if the high-cost flagship model cannot bring matching monopoly-level business returns, traffic will accelerate towards the extremely cost-effective inference end and application-specific chips (ASICs).

Bernstein: Cut Netflix (NFLX.O) price target to $100 from $110.

Citigroup: Raised target price for Johnson & Johnson (JNJ.N) to $298 from $285.